Antimicrobial susceptibility results for a multi-drug resistant Pseudomonas isolated from a case of otitis externa in a dog. Antimicrobial susceptibility.

Slides:



Advertisements
Similar presentations
Direct Sensitivity Performed when : * Gram stain shows large number of one type of reaction * To get quick result for serious cases * Used only.
Advertisements

ANTIBIOTIC By:Afnan Bakhsh. Sir Alexander Fleming (1881 –1955)  “One sometimes finds what one is not  looking for“ Penicillin He observed inhibition.
Second Line Drugs Susceptibility Testing: Study Progress Report Alex Sloutsky Massachusetts State TB Laboratory Paris, 2005.
Augmentin® ES Clinical Microbiology Review
Screening for new antibiotics
Plasmids Chromosome Plasmid Plasmid + Transposon Plasmid + integron Plasmid+transposon +intergron Chromosome Chromosome + transposon Chromosome + transposon.
1 Antimicrobial Therapy Chemotherapy: any treatment of patient with chemicals to treat a condition. –Now word associated with cancer treatment –Our focus.
Office of Drug Evaluation IV, CDER FDA/IDSA/ISAP Workshop 4/16/04 Overview of PK-PD in Drug Development Programs: FDA Perspective FDA/IDSA/ISAP Workshop.
Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.
Overview of Use of PK-PD in Streamlining Drug Development William A. Craig Professor of Medicine University of Wisconsin.
Antibiotics Biotechnology II. Univ S. Carolina Antibiotics Disrupt Cell Wall Synthesis, Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
Chapter 10: Restricting antibiotic use and optimizing dosing.
Jennifer Garcia, DVM, DACVIM.  Is there a bacterial infection there to begin with?  What bacteria is it and what should I use to treat it?  Have I.
PHT 381 Lab # 8. MIC: MIC: It is the lowest concentration of the antimicrobial agent that inhibits the growth of the test organism but not necessarily.
Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 1 Improvement in Dose Selection: FDA Perspective IDSA/ISAP/FDA Workshop.
Control of microbial growth. Antimicrobial Classes Disinfectants –Products aimed at reducing by at least five powers of 10 (99,999 %) the number of microorganisms/virus.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 83 Basic Principles of Antimicrobial Therapy.
Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 In Vitro/Animal Models to Support Dosage Selection: FDA Perspective.
IN THE NAME OF ALLAH ALMIGHTY THE MOST COMPASSIONATE THE MERCIFUL.
PK/PD of Antibiotics in relation to resistance Otto Cars MD Department of Medical Sciences Infectious diseases Uppsala University Sweden.
In Vitro Testing of Antimicrobial Agents Maryam Monajemzadeh, Pathologist Children Medical Center Hospital Tehran University Of Medical Sciences.
Do Physicians Find Our AST Reports As Confusing As We Do? Louis B. Rice, M.D. Louis Stokes Cleveland VA Medical Center and Case Western Reserve University.
Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.
(Antimetabolites) Sulfonamides.
PHT 416 Lab no 10 Minimum Inhibitory Concentration [MIC]
Pharmacodynamics of Antimicrobials in Animal Models William A. Craig, M.D. University of Wisconsin-Madison.
ANTIBIOTICS SUSCEPTIBILITY TESTING
Center for Drug Evaluation and Research Anti-Infective Drug Advisory Committee March 6, New Drug Application NDA /S-008 Cubicin® (daptomycin.
Methods for detecting resistance Goal: To determine whether organism expresses resistances to agents potentially used for therapy Designed to determine.
The Rational Use of Antibiotics
Antibiotic Resistance Emerging antibiotic resistance is a major health concern. 2 million people in the U.S. infected with antibiotic resistant bacteria.
IN THE NAME OF ALLAH ALMIGHTY THE MOST COMPASSIONATE THE MERCIFUL.
PHT 226 Lab no 9. MIC: It is the lowest concentration of the antimicrobial agent that inhibits the growth of the test organism but not necessarily kills.
An agency of the European Union Principles for the assessment and authorisation of antimicrobials in the EU VICH Outreach Forum, October 2015 Presented.
Chapter 42 Antimicrobial Sensitivity Testing
Figure 1. Rate of antimicrobial resistance in S. pneumoniae
Use of antibiotics.
Mapping French population [1]
Antimicrobial Susceptibility Testing (AST)
ANIBIOTICS AND CHEMOTHERAPUETIC AGENTS (I)
Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin- resistant Staphylococcus aureus  Wen-Shiann Wu, Chi-Chung Chen,
Optimizing Aminoglycoside Use
Simone M. Shurland, Ph.D., Division of Anti-Infective Products
in Broth Microdilution Method. M. Albur, A. Noel, K. Bowker, A
D-735/178 50th ICAAC Sept , 2010 Boston
Potential impact of biofilms on bacterial resistance.
Antibiotic Susceptibility Testing
Treatment algorithm for the management of idiopathic epilepsy that I have developed. Treatment algorithm for the management of idiopathic epilepsy that.
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
MIC Where does that number come from?
Antibiotic Resistance Emerging antibiotic resistance is a major health concern. 2 million people in the U.S. infected with antibiotic resistant bacteria.
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.
Successful long-term management of otitis secondary to chronic inflammatory conditions, such as atopic dermatitis, requires ongoing regular anti-inflammatory.
C.G. Giske, C. Borén, B. Wretlind, G. Kronvall 
ANTIBIOTIC RESISTANCE
P. Moreillon, J.M. Entenza  Clinical Microbiology and Infection 
1 Concentration-time curve
Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations  D. Andes, W.A. Craig  Clinical Microbiology.
Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci.
M.R. Jacobs  Clinical Microbiology and Infection 
Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions  M. Sjölund, S. Bengtsson, J. Bonnedahl,
The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines 
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach  J.W. Mouton, D.F.J. Brown, P. Apfalter, R. Cantón,
Figure 1. Susceptibility of all P
Figure 1 MIC test strips showing reversion of daptomycin resistance of isolate 5 passaged in vitro. This figure ... Figure 1 MIC test strips showing reversion.
Fluoroquinolone Nalidixic acid is the predecessor to all fluoroquinolones, a class of man-made antibiotics. Fluoroquinolones in use today typically offer.
Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents    Clinical Microbiology and Infection  Volume.
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
E-strip minimum inhibitory concentration (MIC) assay.
Heteroresistant versus homogeneous responses to antibiotics.
Presentation transcript:

Antimicrobial susceptibility results for a multi-drug resistant Pseudomonas isolated from a case of otitis externa in a dog. Antimicrobial susceptibility results for a multi-drug resistant Pseudomonas isolated from a case of otitis externa in a dog. The results appear to indicate that there are only four suitable antimicrobials, but this is only true for systemic treatment. The row of letters in the reference range represent the range of antimicrobial dilutions that the isolate is cultured with (for enrofloxacin this is [right to left] 2.0 µg/ml, 1.0 µg/ml, 0.5 µg/ml, 0.25 µg/ml). The lower case letters refer to the accepted standards and the upper case letters refer to the actual MIC; in this case, the MIC for enrofloxacin is more than or equal to 2.0 µg/ml (the highest tested concentration). The lower case ‘s’ and ‘r’ ranges show the breakpoint following systemic dosing, ‘i’ refers to intermediate where the breakpoint is uncertain – in practice regard these as resistant. If the MIC falls within the ‘r’ range, then it is unlikely that the drug will attain a therapeutic concentration in the target tissue. Treatment is therefore unlikely to be successful and the infection should be regarded as resistant to that antimicrobial. If, however, the MIC falls within the ‘s’ zone, then it is likely that the drug will exceed the therapeutic concentration in the target tissue. Treatment is likely to be successful, and the infection can be regarded as sensitive to that antimicrobial. Note that use of the term infection rather than bacteria; these results do not mean that an antimicrobial cannot eliminate the bacteria, only that systemic treatment would not be effective in that infection. The bacteria may still be eliminated by a sufficiently high concentration, which is why topical therapy is often effective even when in vitro test results show apparent resistance. This is particularly true for concentration-dependent antimicrobials (eg, aminoglycosides and fluoroquinolones), where the efficacy is proportional to the ratio between concentration and MIC Tim Nuttall In Practice 2016;38:17-21 Copyright © British Veterinary Association. All rights reserved.